Current Pharmacogenomics and Personalized Medicine
Title:Editorial (Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches – Per Ardua Ad Astra?)
Volume: 11 Issue: 1
Author(s): Ana Konvalinka, Sanjeeva Srivastava and Mario Masellis
Affiliation:
Keywords: Idiopathic membranous nephropathy, personalized medicine, proteomics, public health pharmacogenomics, renal pharmacogenomics
Export Options
About this article
Cite this article as:
Konvalinka Ana, Srivastava Sanjeeva and Masellis Mario, Editorial (Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches – Per Ardua Ad Astra?), Current Pharmacogenomics and Personalized Medicine 2013; 11 (1) . https://dx.doi.org/10.2174/1875692111311010002
DOI https://dx.doi.org/10.2174/1875692111311010002 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Disturbed Tryptophan Metabolism in Cardiovascular Disease
Current Medicinal Chemistry Brain Structural Effects of Antidepressant Treatment in Major Depression
Current Neuropharmacology Elevated Plasma Levels of α -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimers Disease: A Potential Therapeutic Target
Current Pharmaceutical Design Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
Current Alzheimer Research Current Diagnostic Modalities for Vulnerable Plaque Detection
Current Pharmaceutical Design Development of Platform Technology for Oral Controlled Delivery of Highly Water Soluble Drugs Using Milnacipran HCl as a Model Drug
Drug Delivery Letters Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Interaction of Prolyl Oligopeptidase with α-Synuclein
CNS & Neurological Disorders - Drug Targets Farewell Note
Recent Patents on CNS Drug Discovery (Discontinued) The Indiana Alzheimer Disease Centers Symposium on Mild Cognitive Impairment. Cognitive Training in Older Adults: Lessons from the ACTIVE Study
Current Alzheimer Research Metabolite Identification and Profiling in Drug Design: Current Practice and Future Directions
Current Pharmaceutical Design Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
Combinatorial Chemistry & High Throughput Screening Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research The Relationship between Social Cognition and Executive Functions in Alzheimer’s Disease: A Systematic Review
Current Alzheimer Research Overview and Developments Regarding Functional Foods and Beverages
Current Nutrition & Food Science Functional Interactions of Tau and their Relevance for Alzheimers Disease
Current Alzheimer Research Diseases Associated with General Amino Acid Transporters of the Solute Carrier 6 Family (SLC6)
Current Molecular Pharmacology The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Clinical Pharmacology of Short Acting Analgo-Sedatives in Neonates
Current Clinical Pharmacology The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry